Advertisement

Rheumatology International

, Volume 6, Issue 2, pp 79–83 | Cite as

Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes

  • J. S. Coppock
  • D. L. Scott
  • S. D. Carter
  • T. M. Moreland
  • M. W. Robinson
Originals

Summary

Fibronectin is involved in the opsonic clearance of particulate material. It is present in plasma and synovial fluid and thus might be expected to have a role in the clearance of immune complexes. We have investigated this in a study of polyethylene glycol (PEG) precipitable material from the serum of patients with rheumatoid arthritis, systemic lupus erythematosus, and other connective tissue disorders. Fibronectin is a significant component of PEG precipitates but the amount present is influenced by the method of preparation: more precipitates at 4°C than at 20°C. Fibronectin precipitation by PEG was considered to be related to immune complexes because: (a) there was no direct relationship between serum fibronectin levels and the amount present in PEG precipitates; (b) radiolabelled purified isolated fibronectin did not precipitate in 4% PEG; (c) there was a direct relationship between the amount of fibronectin in PEG precipitates and the amounts of immunoglobulin G, A, and M. These results indicate that fibronectin is involved in immune complexes in rheumatic diseases, though they do not show it has an important biological role in these circumstances.

Key words

Rheumatoid arthritis Immune complexes Fibronectin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Scott DL, Walton KW (1984) The significance of fibronectin in rheumatoid arthritis. Semin Arthritis Rheum 13:244–254Google Scholar
  2. 2.
    Saba TM, Jaffe E (1980) Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med 68:577–594Google Scholar
  3. 3.
    Ruoslahti E, Engvall E, Hayman EG (1981) Fibronectin; current concepts of its structure and function. Collagen Res 1:95–128Google Scholar
  4. 4.
    Yamada KM, Kennedy DW, Kimata K, Pratt RM (1980) Characterisation of fibronectin interactions with glycosaminoglycans and identification of active proteolystic fragments. J Biol Chem 255:6055–6063Google Scholar
  5. 5.
    Wood G, Rucker M, Davies JW, Entwistle R, Anderson B (1980) Interaction of plasma fibronectin with selected cryoglobulins. Clin Exp Immunol 40:358–364Google Scholar
  6. 6.
    Anderson B, Rucker M, Entwistle R, Schmid FR, Wood GW (1981) Plasma fibronectin is a component of cryoglobulins from patients with connective tissue and other diseases. Ann Rheum Dis 40:50–54Google Scholar
  7. 7.
    Scott DL, Almond TJ, Naqvi SNH, Lea DJ, Stone R, Walton KW (1982) The significance of fibronectin in cryoprecipitation in rheumatoid arthritis and other disorders. J Rheumatol 9:514–518Google Scholar
  8. 8.
    Strevey K, Beaulieu AD, Menard C, Valet JP, Latulippe L, Herbert J (1984) The role of fibronectin in the cryoprecipitation of monoclonal cryoglobulins. Clin Exp Immunol 55:340–346Google Scholar
  9. 9.
    Menzell EJ, Smolen JS, Liotta L, Reid KBM (1981) Interaction of fibronectin with C1q and its collagen-like fragment (CLF). FEBS Lett 129:188–192Google Scholar
  10. 10.
    Hautenen A, Keski-Oja J (1983) Affinity of myeloma IgG proteins for fibronectin. Clin Exp Immunol 53:233–238Google Scholar
  11. 11.
    Carter SD, Scott DL (1984) Fibronectin associated with immunoglobulin aggregates in sera and synovial fluid in rheumatoid arthritis. Br J Rheumatol 23:129Google Scholar
  12. 12.
    Scott DL, Farr M, Crockson AP, Walton KW (1982) Synovial fluid and plasma fibronectin levels in rheumatoid arthritis. Clin Sci 62:71–76Google Scholar
  13. 13.
    Scott DL, Bedford PA, Walton KW (1981) The purification of plasma fibronectin antigen and antiserum. J Immunol Methods 43:29–33Google Scholar
  14. 14.
    Fraker PJ, Speck JC (1978) Protein and cell membrane iodinations with a sparingly soluble chlor-amide 1,4,4 6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun 80:849–857Google Scholar
  15. 15.
    Saba TM, Jaffe E (1980) Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and the role in cardiopulmonary integrity after trauma as related to reticulo-endothelial function. Am J Med 68:577–594Google Scholar
  16. 16.
    Simpson AW, Boughton VJ (1984) Fibronectin as an opsonic regulator of monocyte phagocytosis. J Clin Pathol 37:787–789Google Scholar
  17. 17.
    Hill HR, Shigeoka AO, Augustine NH, Pritchard D, Lundblad JL, Schwartz RS (1984) Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci. J Exp Med 159:1618–1628Google Scholar
  18. 18.
    Morrison P, Edsall R, Miller SG (1948) Preparation and properties of serum and plasma proteins XVIII separation of purified fibrinogen from fraction I of human plasma. J Am Chem Soc 70:3103–3108Google Scholar
  19. 19.
    Edsall JT, Gilbert GA, Scheraga HA (1955) The non-clotting component of the human plasma fraction I-1 (cold insoluble globulin). J Am Chem Soc 77:157–161Google Scholar
  20. 20.
    Edall JT (1978) Some early history of cold insoluble globulin. Ann NY Acad Sci 312:1–10Google Scholar
  21. 21.
    Stathakis NE, Mosesson MW, Chen AB, Galanakis DK (1978) Cryoprecipitation of fibrin-fibrinogen complexes induced by cold insoluble globulin of plasma. Blood 51:1211–1222Google Scholar
  22. 22.
    Stathakis NE, Mosesson MW (1977) Interactions among heparin, cold insoluble globulin and fibrinogen in formation of the heparin-precipitable fraction. J Clin Invest 60:855–865Google Scholar
  23. 23.
    Scott DL, Carter SD, Coppock JS, Robinson MW, Walton KW (1985) Differences between plasma and synovial fluid fibronectin. Rheumatol Int 5:49–54Google Scholar
  24. 24.
    McDonald JA, Baum BJ, Rosenberg DM, Kelman JA, Brin SS, Crystal RG (1979) Destruction of a major extracellular adhesive glycoprotein (fibronectin) of human fibroblasts by neutral proteases from polymorphonuclear leucocyte granules. Lab Invest 40:355–357Google Scholar
  25. 25.
    Humphries MJ, Ayad SR (1983) Stimulation of DNA synthesis by Cathepsin D digests of fibronectin. Nature 305:811–813Google Scholar
  26. 26.
    Wright SD, Craigmyle LS, Silverstein SC (1983) Fibronectin and serum amyloid P component stimulate C3b- and C3bimediated phagocytosis in cultured human monocytes. J Exp Med 158:1338–1343Google Scholar
  27. 27.
    Pommier CG, Inada S, Fries LF, Takahashi T, Frank MM, Brown EJ (1983) Plasma fibronectin enhances phagocytosis of opsonised particles by human peripheral blood monocytes. J Exp Med 157:1844–1854Google Scholar
  28. 28.
    Pommier CG, O'Shea J, Chused T, Yancey K, Frank MM, Takahashi T, Brown EJ (1984) Studies on the fibronectin receptors on human peripheral blood monocytes. Morphological and functional characterisation. J Exp Med 159:137–151Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • J. S. Coppock
    • 2
  • D. L. Scott
    • 1
  • S. D. Carter
    • 2
  • T. M. Moreland
    • 2
  • M. W. Robinson
    • 2
  1. 1.The Department of RheumatologySt. Bartholomew's Hospital Clinical Research CentreLondonUK
  2. 2.The Rheumatism Research Wing, The Medical SchoolUniversity of BirminghamBirminghamUK

Personalised recommendations